Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PT150 Alcohol Interaction Study
NCT03548714Phase 1Completed
- Sponsor
- Pop Test Oncology LLC
- Start
- Sep 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of ORG-34517 in alcohol dependence, sponsored by Pop Test Oncology LLC. Primary endpoints: Change in Breath-alcohol levels (BALs) - Cmax at Day 5, Change in Breath-alcohol levels (BALs) - Tmax at Day 5 and 11 more. Started Sep 2018; status: completed.
02
Drugs
ORG-34517
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT03548714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03548714.